Wednesday, March 29, 2023
Clinical Advances in
Personalized medicine is the tailoring of medical treatment to specific patient characteristics, using genetic profile or disease markers to make treatment decisions. Personalized healthcare extends this further, incorporating factors that stress long range planning in healthcare rather than focusing only on reactionary patient care. This is an educational curriculum to extend understanding of oncologists, ophthalmologists and neurologists on what personalized healthcare means to them, what the benefits and opportunities are to improve patient outcomes, raise awareness of the latest advances and evidence, and provide practical insights and guidance to support optimal practical application in current and emerging practice. The content is guided by an eminent faculty of experts in the field who are committed to providing a broad range of useful resources and educational activities.
Supported by an independent educational grant from
Neurology and Ophthalmology programs presented through a collaboration between Medscape and
Ophthalmology
Artificial Intelligence in Ophthalmology, Optometry and Vision Science: The New Frontier
Deep learning in ophthalmology: The technical and clinical considerations
Artificial intelligence and deep learning in ophthalmology
An Ophthalmologist's Guide to Deciphering Studies in Artificial Intelligence
Steering Committee Chair
Consultant Ophthalmologist
Moorfields Eye Hospital
London, United Kingdom
Consultant Ophthalmologist
Division of Pharmacy and Optometry
University of Manchester
Manchester, United Kingdom
Assistant Professor of Neurology
UCSF Weill Institute for Neurosciences
School of Medicine
University of California
San Francisco, California, United States
Head of the Department of Biomedical Engineering
University of Basel
Basel, Switzerland
Assistant Professor
Department of Ophthalmology
University of Washington
Seattle, Washington, United States
Head of Department of Brain Sciences
Faculty of Medicine
Imperial College London
London, United Kingdom
General Director
Centre Leon Berard
Lyon, France
Oncology Data Science Group Leader
Vall D'Hebron Institute Of Oncology
Barcelona, Spain
Professor
Deputy Director of Medical Oncology
Peter MacCallum Cancer Centre Melbourne, Australia
Professor of Pathology
University Zurich
Chairman of the Institute for Pathology and Molecular Pathology
University Hospital
Zurich, Switzerland
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Apellis Pharmaceuticals; DeepMind; Novartis AG; Roche
Served as a speaker or a member of a speakers bureau for: Allergan; Bayer AG; Heidelberg Engineering; Novartis AG; Santen Pharmaceutical Co., Ltd.; Topcon
Owns stock, stock options, or bonds from: Big Picture Eye Health
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Adelphi Communications; Biogen; Celgene Corporation; Ipsen; Neurodiem; Roche
Served as a speaker or a member of a speakers bureau for: Biogen; Celgene Corporation; Novartis AG; Roche
Received grants for clinical research from: Biogen; GlaxoSmithKline
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biogen; EMD Serono, Inc.; Genentech, Inc.; Genzyme Corporation; Novartis Pharmaceuticals Corporation; Roche; Sanofi
Received grants for clinical research from: Akili Interactive
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Genentech, Inc.; Verana Health
Served as a speaker or a member of a speakers bureau for: Topcon
Received grants for clinical research from: Carl Zeiss Meditec; Microsoft; Novartis AG; Nvidia
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan; Bausch and Lomb; Bayer, Novartis; Oray; Thea Pharmaceuticals
Served as a speaker or a member of a speakers bureau for: Allergan; Bausch and Lomb; Bayer, Novartis; Oray; Thea Pharmaceuticals
Received grants for clinical research from: Allergan; Bausch and Lomb; Bayer, Novartis; Oray; Thea Pharmaceuticals
Owns stock, stock options, or bonds from: Clin-e-cal Ltd
Steering Committee Member
Has disclosed no relevant financial relationships.
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen Inc.; Bayer AG; Ipsen; Roche
Served as a speaker or a member of a speakers bureau for: Roche
Received grants for clinical research from: Roche
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare; Deciphera; Pharmamar; Roche Holdings AG
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Bristol-Myers Squibb Company; GlaxoSmithKline; Mercl Sharp & Dohme Corp; Novartis Pharmaceuticals Corporation; Roche Holdings AG; Pharmamar
Other: Innate Pharma
Steering Committee Member
Has disclosed no relevant financial relationships.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Boehringer Ingelheim Pharmaceuticals, Inc.; Roche
Served as a speaker or a member of a speakers bureau for: Amgen Inc.; Ipsen; Merck Sharp & Dohme Corp.; Roche; Sanofi; SERVIER
Received grants for clinical research from: Pierre Fabre